Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Unity Software Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Unity Software Inc trades at $40.93 (market cap $20.52B). The key difference: Unity Software Inc is far larger — about 2.3× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is more actively traded (779,107 versus 4,656,122). Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Unity Software Inc for 50 Days on average.
| KYMR | U | |
|---|---|---|
Market Cap | $8.87B | $20.52B |
Volume | 779,107 | 4,656,122 |
Sector | Health | Technology |
52-Week High | $127.31 | $49.47 |
52-Week Low | $55.80 | $17.13 |
Typical Hold Time | 0 Days | 50 Days |
Enterprise Value | $8.26B | $20.41B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Unity Software (U) trades at $41.40, down 11.31% over 24 hours, with a bullish technical outlook despite recent volatility. The company shows improving fundamentals with revenue stabilizing around $1.8B and narrowing losses, while strategic partnerships like Meta VR support drive positive sentiment. Analyst consensus remains strongly bullish with 82.76% buy ratings and a $48.01 price target, representing 16% upside potential from current levels.
Unity presents a growth opportunity with accelerating strategic revenue and margin expansion, though persistent net losses and high valuation multiples pose risks. The stock's outlook depends on continued execution of the advertising platform transformation and VR market penetration, with technical support at $45-46 providing near-term stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
